Can a 3-Step exercise plan become standard in cancer care?

NCT ID NCT07210905

Not yet recruiting Knowledge-focused Sponsor: The University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a simple 3-step exercise protocol (assess, advise, refer) can be made a standard part of cancer care. Researchers will train clinic staff and track how many eligible patients are screened and referred to a weight management program. About 1,800 cancer survivors who finished treatment within the past five years will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 3-step Assess-Advise-Refer exercise protocol (FitARise)
What this could lead to: If successful, this could make exercise counseling a routine part of cancer care, helping more patients get support to improve their health after treatment.
What could go wrong: This is an implementation study, not a test of a new drug or treatment. It focuses on changing how clinics work, so even if it succeeds, direct patient benefits may take time and may not be seen in all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Motor Activity neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER CANCER (COLON CANCER, BREAST CANCER, LYMPHOMA, CHRONIC LYMPHOMA LEUKEMIA, MULTIPLE MYELOMA) EXERCISE

Contacts and locations

Locations

KWH Department of Surgery

Hong Kong, Hong Kong
PMH Department of Oncology

Hong Kong, Hong Kong
PYEH Department of Clinical Oncology

Hong Kong, Hong Kong
QMH Department of Clinical Oncology

Hong Kong, Hong Kong
QMH Department of Obstetrics and Gynaecology

Hong Kong, Hong Kong
QMH Department of Surgery

Hong Kong, Hong Kong
TMH Department of clinical oncology

Hong Kong, Hong Kong
YCH Surgery Department

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.